Pruden, who’s worked at J&J for 32 years, is due to be replaced by worldwide chairwoman Sandi Peterson, the company said.
“As the leader of global surgery, Gary transformed the surgery, cardiovascular and specialty businesses, accelerating their growth and elevating the innovation agenda, most notably by driving a collaboration with Google to develop a transformational robotic surgery platform,” Johnson & Johnson said in prepared remarks.
Peterson already leads J&J’s consumer, consumer medical device and health & wellness businesses; she’s also in charge of infrastructure areas including supply chain, IT, global design and health technology. Peterson joined Johnson & Johnson from Bayer Crop Sciences in September 2012.
“Since joining the company more than four years ago, Sandi has been a valuable partner and has played a critical role in positioning Johnson & Johnson to thrive in a rapidly changing environment,” chairman & CEO Alex Gorsky said in prepared remarks. “Under Sandi’s leadership, our Consumer and Consumer Medical Device businesses have improved significantly, and the quality and efficiency of our operating infrastructure have been notably strengthened. Sandi has a proven track record and brings broad-based experience and a strategic, global perspective to our Hospital Medical Device business.”